These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 9738626)

  • 41. Adverse reactions in blood and apheresis donors: experience from two Italian transfusion centres.
    Crocco I; Franchini M; Garozzo G; Gandini AR; Gandini G; Bonomo P; Aprili G
    Blood Transfus; 2009 Jan; 7(1):35-8. PubMed ID: 19290078
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Assessment of serum iron stores in regular plateletpheresis donors.
    Chinigi Sab P; Kaur G; Kaur P; Tahlan A; Bedi RK; Mittal K; Sood T
    Transfus Apher Sci; 2022 Feb; 61(1):103291. PubMed ID: 34649790
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Are Bradycardic Donors More Likely to Have Adverse Outcomes During Blood Donation?
    Broadwater DR; Krause KA; Lynch DT; Kendelhardt JD
    Mil Med; 2023 May; 188(5-6):e1018-e1021. PubMed ID: 34668966
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The relationship of platelet yield, donor's characteristic and apheresis instruments in China.
    Yin G; Xu J; Shen Z; Wang Y; Zhu F; Lv H
    Transfus Apher Sci; 2013 Dec; 49(3):608-12. PubMed ID: 23978555
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Implications of a switch to a 100% apheresis platelet supply for patients and for blood donors: a risk benefit analysis.
    Thiele T; Alt-Mayer T; Greinacher A; Bux J
    Vox Sang; 2016 Nov; 111(4):350-356. PubMed ID: 27432635
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Frequent plateletpheresis donations & its effect on haematological parameters: An observational study.
    Nayak S; Coshic P; Pandey RM; Chatterjee K
    Indian J Med Res; 2019 Nov; 150(5):468-476. PubMed ID: 31939390
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Impact of a post-donation hemoglobin testing strategy on efficiency and safety of whole blood donation in England: A modeling study.
    Kim LG; Bolton T; Sweeting MJ; Bell S; Fahle S; McMahon A; Walker M; Ferguson E; Miflin G; Roberts DJ; Di Angelantonio E; Wood AM
    Transfusion; 2023 Mar; 63(3):541-551. PubMed ID: 36794597
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Efficacy and safety of plateletpheresis by donors with low-normal platelet counts.
    Rogers RL; Johnson H; Ludwig G; Winegarden D; Randels MJ; Strauss RG
    J Clin Apher; 1995; 10(4):194-7. PubMed ID: 8770712
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Frequent plateletpheresis does not clinically significantly decrease platelet counts in donors.
    Katz L; Palmer K; McDonnell E; Kabat A
    Transfusion; 2007 Sep; 47(9):1601-6. PubMed ID: 17725723
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pseudothrombocytopenia in plateletpheresis donors.
    Sweeney JD; Holme S; Heaton WA; Campbell D; Bowen ML
    Transfusion; 1995 Jan; 35(1):46-9. PubMed ID: 7998068
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The selection of donors in multicomponent collection management.
    Bonomo P; Garozzo G; Bennardello F
    Transfus Apher Sci; 2004 Feb; 30(1):55-9. PubMed ID: 14746822
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Ensuring donor safety: is venesecting therapeutic donors to haemoglobin levels below Blood Service guidelines safe?
    Lim Z; Bentley P; Olynyk JK
    Vox Sang; 2020 May; 115(4):288-292. PubMed ID: 32080874
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Frequency of adverse events in plateletpheresis donors in regional transfusion centre in North India.
    Patidar GK; Sharma RR; Marwaha N
    Transfus Apher Sci; 2013 Oct; 49(2):244-8. PubMed ID: 23830186
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Iron stores in autologous blood donors.
    Sthabunswadigarn S; Tardtong P; Atamasirikul K; Suwannuruk R; Suddhasthira T
    J Med Assoc Thai; 2000 Mar; 83 Suppl 1():S137-40. PubMed ID: 10865420
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparison of random-donor platelet concentrates prepared from whole blood units and platelets prepared from single-donor apheresis collections.
    Sloand EM; Yu M; Klein HG
    Transfusion; 1996; 36(11-12):955-9. PubMed ID: 8937403
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Repeated apheresis donations cause important iron deficiency in male Japanese donors.
    Odajima T; Tsuno NH; Iwasaki J; Matsuzaki K; Ishimaru F; Okubo R; Murakami J; Kitsukawa K; Ikuta K; Muroi K; Satake M; Kino S
    Vox Sang; 2024 Aug; ():. PubMed ID: 39134074
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Blood donors--Serious adverse reactions (SAR) 2010-2014 EFS Châteauroux, France.
    Riga A; Sapey T; Bacanu M; Py JY; Dehaut F
    Transfus Clin Biol; 2015 Jun; 22(2):62-5. PubMed ID: 25997383
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A study of serum ferritin levels among male blood donors in Hospital Universiti sains Malaysia.
    Norashikin J; Roshan TM; Rosline H; Zaidah AW; Suhair AA; Rapiaah M
    Southeast Asian J Trop Med Public Health; 2006 Mar; 37(2):370-3. PubMed ID: 17125001
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Determination of serum ferritin: ideas for avoiding induced ferropenia in blood donors].
    Hernández Lamas MC; López Pérez-Lanzac JC; Prat Arrojo I; Sánchez Gordo F; Arleth Christensen E; Sánchez Font E
    Sangre (Barc); 1994 Feb; 39(1):9-14. PubMed ID: 8197526
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prevalence and predictors of adverse reactions in plateletpheresis donors with the perspective of donor safety in a tertiary care hospital of Northern India.
    Solanki A; Katharia R; Singh A; Chauhan A; Chandra T; Sonker A; Agarwal P
    Asian J Transfus Sci; 2020; 14(1):44-48. PubMed ID: 33162705
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.